Notes - Segment Information

Astellas Pharma Inc. - Filing #7604918

Concept 2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
Notes - Segment information
Segment information
Revenue
Revenue
1,296,163,000,000 JPY
1,249,528,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
489,000,000 JPY
478,000,000 JPY
Profit (loss) before tax
156,886,000,000 JPY
145,324,000,000 JPY
Assets
2,332,395,000,000 JPY
2,273,628,000,000 JPY
Investments accounted for using equity method
10,035,000,000 JPY
7,117,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.